Farther Finance Advisors’s Trinity Biotech TRIB Stock Holding History

Farther Finance Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-67	Closed	-$778	–	6334
2026 Q2	$778	Hold	67	–	–	﹤0.01%	5434
2026 Q1	$1.2K	Hold	67	–	–	﹤0.01%	5056
2025 Q4	$1.58K	Hold	67	–	–	﹤0.01%	4777
2025 Q3	$2.08K	Hold	67	–	–	﹤0.01%	4128
2025 Q2	$1.3K	Hold	67	–	–	﹤0.01%	3836
2025 Q1	$1.14K	Buy	+67	New	+$1.59K	﹤0.01%	3569

Farther Finance Advisors's TRIB Position: Q3 2026 in Review

Farther Finance Advisors sold out of Trinity Biotech (TRIB) in Q3 2026, closing a stake of 67 shares — an estimated $778 sold.

Farther Finance Advisors first reported a position in TRIB in Q1 2025 and held it in 6 quarters. The position peaked at $2.08K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRIB as of Q3 2026.

Farther Finance Advisors reported no remaining Trinity Biotech position as of Q3 2026 after selling out during the quarter.
Farther Finance Advisors sold 67 Trinity Biotech shares in Q3 2026, an estimated $778.
Farther Finance Advisors first reported a position in Trinity Biotech in Q1 2025 and held it in 6 quarters.
Farther Finance Advisors's Trinity Biotech position peaked at $2.08K in Q3 2025.
0 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.